2021
DOI: 10.1172/jci152386
|View full text |Cite
|
Sign up to set email alerts
|

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

Abstract: JBR has served as an advisor to GlaxoSmithKline and Deerfield Capital. His institution has received investigator-initiated grant funding from Eli Lilly, GlaxoSmithKline and Biogen for projects unrelated to this paper. DP has served as an advisory board, and has received travel/research grants, speaking and teaching fees for Macopharma,

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

11
61
1
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 95 publications
(74 citation statements)
references
References 48 publications
11
61
1
1
Order By: Relevance
“…It is important to remark that these association signals found in males were not associated with the presence of comorbidities (see Supplementary Figure 4). In fact, genetic effects were only found for younger males (<60 years old), consistent with other studies [25] and strongly supporting those comorbidities outweigh genetic effects in disease outcomes in the older patients.…”
Section: Discussionsupporting
confidence: 90%
“…It is important to remark that these association signals found in males were not associated with the presence of comorbidities (see Supplementary Figure 4). In fact, genetic effects were only found for younger males (<60 years old), consistent with other studies [25] and strongly supporting those comorbidities outweigh genetic effects in disease outcomes in the older patients.…”
Section: Discussionsupporting
confidence: 90%
“…Acquired HLH/MAS complicates diverse, mostly viral, infections, malignancies, autoimmune and autoinflammatory disorders ( Brisse et al., 2016a ), and treatment with chimeric antigen receptor (CAR) T cells ( Neelapu et al., 2018 ). Five of six candidate genes at the major 3p21.31 risk locus for severe COVID-19 ( Ellinghaus et al., 2020 ; Nakanishi et al, 2021 ; Pairo-Castineira et al., 2021 ) point toward DC-T cell interactions ( Kaser, 2020 ), remarkable as that hyperinflammation shares features with HLH/MAS, including hemophagocytosis ( Lucas et al., 2020 ; Prieto-Pérez et al., 2020 ). It remains unclear why excessive T cell activation by FAMIN-impaired DCs results in enhanced immunosurveillance of tumors but fails to control IAV infection.…”
Section: Discussionmentioning
confidence: 99%
“…9,10 ) and an over twofold increased risk of mortality for individuals under 60 (ref. 13 ). Additionally, the risk variants at this locus are carried by >60% of individuals with South Asian ancestry (SAS), compared to 15% of European ancestry (EUR) groups, partially explaining the ongoing higher death rate in this population in the UK 14,15 .…”
mentioning
confidence: 99%